Why 'miracle' weight loss drugs are about to get 50% cheaper in India

The country’s anti-obesity market is headed for a pricing shake-up. A clutch of pharma companies is preparing to launch more affordable versions of blockbuster weight-loss medicines such as Wegovy and Ozempic.
This could significantly alter who can access medical treatment for obesity in India. Until now, such drugs have remained largely confined to affluent urban patients and private clinics, because of their high monthly cost and the need for long-term use.